Insider filing · ADRX
Carl L Gordon
Director
profile →
ADARx Pharmaceuticals, Inc.
ADRX · Healthcare · 5 filings in 24 months
ticker →
Carl L Gordon bought $16.1M of ADARx Pharmaceuticals (ADRX)
Executed Sep 28, disclosed Sep 30, 2 days later.
Value, as filed
$16.1M
950,000 sh across 3 lots
Executed
Sep 28
the trade date, as filed
Disclosed
Sep 30
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
CGCarl L Gordon (Director) filed 4 Form 4 reports in the trailing twelve months (4 purchases, 0 sales), most often in ADARx Pharmaceuticals, Inc. (ADRX). Across 2 priced purchase filings, the average 21-session return was +56.2% from execution and +52.9% from disclosure (delay-adjusted; derived). The largest single filing was $20.0M of ETRA (1,333,333 sh across 2 lots, as filed), executed Sep 21.
The name
ADRXHealthcare · ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a bro…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→